These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 27835580)

  • 1. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation.
    Cha PH; Cho YH; Lee SK; Lee J; Jeong WJ; Moon BS; Yun JH; Yang JS; Choi S; Yoon J; Kim HY; Kim MY; Kaduwal S; Lee W; Min do S; Kim H; Han G; Choi KY
    Nat Chem Biol; 2016 Aug; 12(8):593-600. PubMed ID: 27294323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab.
    Lee SK; Cho YH; Cha PH; Yoon JS; Ro EJ; Jeong WJ; Park J; Kim H; Il Kim T; Min DS; Han G; Choi KY
    Exp Mol Med; 2018 Nov; 50(11):1-12. PubMed ID: 30459318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling.
    Shin W; Lee SK; Hwang JH; Park JC; Cho YH; Ro EJ; Song Y; Seo HR; Choi KY
    Exp Mol Med; 2018 Jun; 50(6):1-10. PubMed ID: 29884842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3β.
    Lee SK; Jeong WJ; Cho YH; Cha PH; Yoon JS; Ro EJ; Choi S; Oh JM; Heo Y; Kim H; Min DS; Han G; Lee W; Choi KY
    EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30413483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells.
    Cho YH; Ro EJ; Yoon JS; Kwak DK; Cho J; Kang DW; Lee HY; Choi KY
    Cell Commun Signal; 2020 Mar; 18(1):38. PubMed ID: 32143715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
    Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
    Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
    Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
    J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
    Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
    J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/β-catenin signaling pathway.
    Yang MH; Ha IJ; Lee SG; Lee J; Um JY; Ahn KS
    IUBMB Life; 2021 Oct; 73(10):1222-1234. PubMed ID: 34273236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule Destabilizer of β-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors.
    Choi JK; Cho H; Moon BS
    Target Oncol; 2020 Oct; 15(5):645-657. PubMed ID: 33026592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.